Parametric Portfolio Associates’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$3.23M	Buy	198,832 +70,189	+55%	+$1.13M	﹤0.01%	2138
2021 Q4	$1.78M	Sell	128,643 -100,413	-44%	-$1.33M	﹤0.01%	2503
2021 Q3	$3.29M	Buy	229,056 +9,042	+4%	+$143K	﹤0.01%	2123
2021 Q2	$3.48M	Buy	220,014 +118,825	+117%	+$1.61M	﹤0.01%	2111
2021 Q1	$1.03M	Buy	101,189 +16,655	+20%	+$172K	﹤0.01%	3154
2020 Q4	$630K	Buy	84,534 +189	+0.2%	+$974	﹤0.01%	3274
2020 Q3	$290K	Sell	84,345 -457,784	-84%	-$1.96M	﹤0.01%	3499
2020 Q2	$2.58M	Buy	542,129 +492,761	+998%	+$1.97M	﹤0.01%	2335
2020 Q1	$99K	Buy	49,368 +17,849	+57%	+$49.1K	﹤0.01%	3733
2019 Q4	$109K	Sell	31,519 -25,099	-44%	-$63.1K	﹤0.01%	3849
2019 Q3	$162K	Buy	56,618 +39,963	+240%	+$124K	﹤0.01%	3755
2019 Q2	$63K	Sell	16,655 -112,651	-87%	-$678K	﹤0.01%	3893
2019 Q1	$1.05M	Buy	129,306 +13,196	+11%	+$113K	﹤0.01%	3005
2018 Q4	$937K	Buy	+116,110	New	+$903K	﹤0.01%	3020
2018 Q3	–	Sell	-14,284	Closed	-$82K	–	3940
2018 Q2	$82K	Buy	14,284 +1,407	+11%	+$7.75K	﹤0.01%	3822
2018 Q1	$61K	Buy	12,877 +1,157	+10%	+$5.95K	﹤0.01%	3894
2017 Q4	$58K	Buy	11,720 +648	+6%	+$3.14K	﹤0.01%	3859
2017 Q3	$58K	Buy	+11,072	New	+$56.7K	﹤0.01%	3986
2014 Q4	–	Sell	-14,960	Closed	-$146K	–	3982
2014 Q3	$146K	Buy	+14,960	New	+$183K	﹤0.01%	3676